Tibet Weixinkang Medicine Co Ltd (603676) — Cash Flow Quality Index
Tibet Weixinkang Medicine Co Ltd (603676) has a Cash Flow Quality Index of 0.38x as of September 2025. Operating cash flow of CN¥13.68 Million is below net income of CN¥36.39 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Tibet Weixinkang Medicine Co Ltd total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Tibet Weixinkang Medicine Co Ltd Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for Tibet Weixinkang Medicine Co Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 603676 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Tibet Weixinkang Medicine Co Ltd (2013–2024)
Year-by-year earnings quality comparison for Tibet Weixinkang Medicine Co Ltd. For live market cap and the full company financial profile, see market value of Tibet Weixinkang Medicine Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.51x | CN¥372.78 Million | CN¥246.17 Million | ▲ +26.3% |
| 2023 | 1.20x | CN¥256.67 Million | CN¥214.02 Million | ▼ -13.8% |
| 2022 | 1.39x | CN¥246.15 Million | CN¥176.96 Million | ▼ -21.8% |
| 2021 | 1.78x | CN¥170.69 Million | CN¥95.91 Million | ▼ -22.2% |
| 2020 | 2.29x | CN¥133.70 Million | CN¥58.42 Million | ▲ +19.8% |
| 2019 | 1.91x | CN¥106.34 Million | CN¥55.68 Million | ▲ +68.6% |
| 2018 | 1.13x | CN¥83.17 Million | CN¥73.44 Million | ▲ +81.8% |
| 2017 | 0.62x | CN¥63.30 Million | CN¥101.59 Million | ▼ -31.0% |
| 2016 | 0.90x | CN¥103.79 Million | CN¥114.92 Million | ▼ -10.8% |
| 2015 | 1.01x | CN¥114.47 Million | CN¥113.03 Million | ▼ -0.7% |
| 2014 | 1.02x | CN¥118.47 Million | CN¥116.20 Million | ▲ +1.0% |
| 2013 | 1.01x | CN¥88.59 Million | CN¥87.74 Million | — |